The Case for Practical Clinical Trials in Psychiatry
- 1 May 2005
- journal article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 162 (5) , 836-846
- https://doi.org/10.1176/appi.ajp.162.5.836
Abstract
Clinical trials in psychiatry frequently fail to maximize clinical utility for practicing clinicians, or, stated differently, available evidence is not perceived by clinicians (and other decision makers) as sufficiently relevant to clinical practice, thereby diluting its impact. To attain maximum clinical relevance and acceptability, researchers must conduct clinical trials designed to meet the needs of clinicians and others who are making decisions about patients' care. The authors present the case for psychiatry's adoption of the practical clinical trials model, which is widely used in research in other areas of medicine. The authors outline the characteristics and scope of practical clinical trials, give examples of practical clinical trials, and discuss the challenges of using the practical clinical trials model in psychiatry, including issues of funding. Practical clinical trials, which are intended to provide generalizable answers to important clinical questions without bias, are characterized by eight key features: a straightforward clinically relevant question, a representative sample of patients and practice settings, sufficient power to identify modest clinically relevant effects, randomization to protect against bias, clinical uncertainty regarding the outcome of treatment at the patient level, assessment and treatment protocols that enact best clinical practices, simple and clinically relevant outcomes, and limited subject and investigator burden. To implement the practical clinical trials model in psychiatry will require stable funding for network construction and maintenance plus methodological innovation in governance and trial selection, assessment, treatment, data management, site management, and data analytic procedures.Keywords
This publication has 58 references indexed in Scilit:
- NIH Director Elias A. Zerhouni, MD, Reflects on Agency's Challenges, PrioritiesPublished by American Medical Association (AMA) ,2003
- Central Challenges Facing the National Clinical Research EnterpriseJAMA, 2003
- Clozapine Treatment for Suicidality in SchizophreniaInternational Suicide Prevention Trial (InterSePT)Archives of General Psychiatry, 2003
- Mediators and Moderators of Treatment Effects in Randomized Clinical TrialsArchives of General Psychiatry, 2002
- Monitoring and ensuring safety during clinical research.JAMA, 2001
- Agenda for child and adolescent psychotherapy research: on the need to put science into practice.Archives of General Psychiatry, 2000
- Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity DisorderArchives of Pediatrics & Adolescent Medicine, 1999
- Psychiatric Patients and Treatments in 1997Archives of General Psychiatry, 1999
- Variation in Carotid Endarterectomy Mortality in the Medicare PopulationJAMA, 1998
- Users' guides to the medical literatureJAMA, 1993